
20S Proteasome activator 1
CAS No. 2761578-18-9
20S Proteasome activator 1 ( —— )
产品货号. M35713 CAS No. 2761578-18-9
20S Proteasome activator 1 是一种有效的 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 能在细胞系统中翻译,防止致病性 α-synuclein A53T 突变体积累。20S Proteasome activator 1 可用于神经退行性疾病的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥517 | 有现货 |
![]() ![]() |
10MG | ¥791 | 有现货 |
![]() ![]() |
25MG | ¥1501 | 有现货 |
![]() ![]() |
50MG | ¥2565 | 有现货 |
![]() ![]() |
100MG | ¥4116 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称20S Proteasome activator 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述20S Proteasome activator 1 是一种有效的 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 能在细胞系统中翻译,防止致病性 α-synuclein A53T 突变体积累。20S Proteasome activator 1 可用于神经退行性疾病的研究。
-
产品描述20S Proteasome activator 1 is a potent 20S proteasome activator with EC200 values of 0.3 μM, 0.7 μM and 1.8 μM for trypsin-like site, chymotrypsin-like site and caspase-like site. 20S Proteasome activator 1 translates well in a cellular system, preventing the accumulation of the pathogenic A53T mutant of α-synuclein. 20S Proteasome activator 1 can be used for researching neurodegenerative diseases.
-
体外实验20S Proteasome activator 1 (compound 19) (2.5-15 μM; 45 min) degrades 73% α-synuclein at 10 μM, and over 80% at 15 μM.20S Proteasome activator 1 (5-15 μM; 24 h) reduces 25% A53T mutant, and dose-dependently reduces enhancement of α-synuclein in Hek-293T cells (transiently transfected with an A53T mutant α-synuclein plasmid) at 5 μM; decreases 67% A53T α-synuclein at 15 μM.
-
体内实验——
-
同义词——
-
通路Proteasome/Ubiquitin
-
靶点Proteasome
-
受体Proteasome
-
研究领域——
-
适应症——
化学信息
-
CAS Number2761578-18-9
-
分子量492.97
-
分子式C27H19ClF2N2OS
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (202.85 mM; 超声助溶 )
-
SMILESC(CC(N(C1=CC=C(F)C=C1)C2=CC=C(F)C=C2)=O)N3C=4C(SC=5C3=CC=CC5)=CC=C(Cl)C4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Staerz SD, et al. Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies. J Med Chem. 2022 May 12;65(9):6631-6642.?
产品手册




关联产品
-
Bortezomib-pinanedio...
Bortezomib-pinanediol 是一种蛋白酶体抑制剂。是硼替佐米的前药。
-
Capzimin
Capzimin(Rpn11 抑制剂 3027)是 8TQ 的衍生物,是蛋白酶体异构肽酶 Rpn11 的有效且特异性抑制剂,IC50 为 0.34 uM。
-
Protocatechualdehyde
原儿茶醛是一种天然存在的酚醛。